Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
A Phase II, Open Label Clinical Trial Exploring the Safety and the Efficacy of Oral Deferasirox in Patients Newly Diagnosed With Porphyria Cutanea Tarda (PCT) and Non-transfusion Iron Overload A Phase II, Open Label Clinical Trial Exploring the Safety and the Efficacy of Oral Deferasiroxin Pa ...